Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07307326 · ClinicalTrials.gov registry record · NA
Biomarker Feedback Intervention
A NA study, sponsored by Penn State University.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07307326 is a NA study that has not yet begun recruiting, run by Penn State University. The registered enrollment target is 150 participants.
The verdict
NCT07307326, a NA study, has not yet begun recruiting, sponsored by Penn State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of the study is to examine alcohol use behaviors of young adults through the use of testing the feasibility of adding an innovative brief personalized alcohol biomarker feedback component (TAC feedback) to an existing efficacious personalized feedback intervention, eCHECKUP TO GO (eCTG), and how (if at all) the intervention impacts drinking behaviors in high-risk college students. The study will conduct a feasibility assessment of the TAC feedback component, and will also assess the effects of the eCTG + TAC at 6-months post-baseline relative to an eCTG only group.
Interventions
- BEHAVIORAL eCHECKUP TO GO (eCTG)
- BEHAVIORAL eCHECKUPTOGO + brief personalized alcohol biomarker feedback intervention (eCTG + TAC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-10-15 |
| Est. Completion | 2027-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07307326
The ClinicalTrials.gov registry entry for NCT07307326 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which eCHECKUP TO GO (eCTG) is the first listed.
NCT07307326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07307326 about?
NCT07307326 is a clinical study titled "Biomarker Feedback Intervention". The goal of the study is to examine alcohol use behaviors of young adults through the use of testing the feasibility of adding an innovative brief personalized alcohol biomarker feedback component (TAC feedback) to an existing efficacious personalized feedback intervention, eCHECKUP TO GO (eCTG), an...
What is the current status of trial NCT07307326?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-10-15. Estimated completion is 2027-12-15.
What interventions are being tested in trial NCT07307326?
The interventions under investigation include: eCHECKUP TO GO (eCTG) (BEHAVIORAL), eCHECKUPTOGO + brief personalized alcohol biomarker feedback intervention (eCTG + TAC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07307326?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.